Roche Holding AG said Monday that Phase 3 Graduate studies of gantenerumab, for treatment of early Alzheimer’s disease, failed to meet its primary endpoints. The Swiss pharma company ROG, -3.72% Read more
Tag: drug
Medical cannabis maker Cantourage surges in Frankfurt debut
Medical cannabis maker Cantourage soared in its debut in Frankfurt on Friday. With the ticker symbol “HIGH,” shares of the Berlin-based company HIGH, +136.11% rose as high as €19.70 after Read more
Aurora Cannabis reports bigger loss than expected, but execs stick with profit target
Aurora Cannabis Inc. on Thursday reported a bigger quarterly loss and lower sales than expected, but the Canadian pot producer stuck with its target of hitting an adjusted measure of Read more
Juul secures financing to avoid bankruptcy and plans to cut 30% of jobs globally
Juul Labs Inc. has secured a cash infusion from some of its early investors to stave off bankruptcy and plans to lay off about a third of its global staff, company Read more
Wana Brands CEO makes seven-figure donation to fund cannabis research
Wana Brands founder and CEO Nancy Whiteman is stepping up her charitable activities with $3 million for cannabis and psychedelic medicine research at Johns Hopkins University — the largest donation Read more
Voters approve cannabis use for adults in one red state, one blue state
Industry pundits mostly praised the mixed results for cannabis votes in Tuesday’s midterm elections, as Maryland and Missouri became the 20th and 21st U.S. states to allow adults over 21 Read more
Maryland may become 20th state to OK cannabis for adults
Voters in Arkansas, Maryland, Missouri, North Dakota and South Dakota are weighing in on legal cannabis today, with measures on the ballot in each of those states. The state most Read more
Curaleaf earnings show legal U.S. weed sales flattening out as prices decline
U.S. cannabis producer Curaleaf Holdings Inc. on Monday reported a bigger loss than expected during its third quarter, amid what it said were “unexpected revenue impacts” in Florida and New Read more
Amid steep inflation, one thing is getting cheaper: cannabis
U.S. consumers continue to face the highest prices in decades for gasoline and other products, but if they’re in a state that allows sales of cannabis, at least they’re paying Read more
Amid steep inflation, one thing is getting cheaper: cannabis
U.S. consumers continue to face the highest prices in decades for gasoline and other products, but if they’re in a state that allows sales of cannabis, at least they’re paying Read more